![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Previous Article | Next Article 
Infection and Immunity, November 1998, p. 5543-5546, Vol. 66, No. 11
Institut für Klinische Mikrobiologie,
Received 15 May 1998/Returned for modification 29 June
1998/Accepted 5 August 1998
In this study, cytokine patterns produced by CD4+ T
cells isolated from antrum or corpus gastral biopsy specimens of 10 patients with Helicobacter pylori-positive gastritis were
compared. To this end, expression of intracellular cytokines
(interleukin-4 [IL-4] and gamma interferon) and of CD4 was assessed
by flow cytometry. Ten to 60% of the isolated CD4+ T cells
produced gamma interferon upon stimulation. With the exception of one
patient, IL-4-positive CD4+ cells were not detected.
Therefore, CD4+ cells infiltrating antrum and corpus
stomach mucosa during H. pylori infection show a Th1
phenotype. This polarized Th1-type response may contribute to the
inability of the immune system to eradicate H. pylori
infection.
Originally described in 1983 (26), Helicobacter pylori is now considered an
important human pathogen causing gastritis and duodenal ulceration
(16, 21). In addition, infection with H. pylori
has been associated with gastric lymphoma (20, 27) and seems
to be a risk factor for adenocarcinoma of the stomach (11).
Several pathogenic factors of H. pylori, including the cytotoxin VacA and the protein CagA, may contribute to the pathogenesis of disease (3, 4). In addition, host factors may also play a
pathogenic role, because autoantibodies appear during H. pylori infection in certain patients (1, 8, 18). Once a
person is infected, H. pylori can persist in the stomach for
decades despite a systemic immune response (23). The reasons
for the failure of the immune system to control infection are not yet completely understood. It is therefore of importance to analyze systemic and local T- and B-cell responses in patients chronically infected with H. pylori. Respective immunological studies
have shown that the numbers of CD4+ and CD8+ T
cells are increased in the gastric mucosa of patients with H. pylori gastritis (10, 19) and that T cells isolated
from the antrum region are able to produce gamma interferon (IFN- For this reason, in this study the cytokine profiles of gastric T cells
derived from the corpus and antrum regions of the stomach were
compared. To this end, cytokines (IFN- Biopsy specimens from a total of 43 patients were analyzed in this
study. After exclusion of patients with other gastric disorders (e.g.,
H. pylori-negative gastritis, gastritis induced by
nonsteroidal anti-inflammatory drugs, malignancies), 30 patients (12 females and 18 males; age range, 22 to 82 years) remained for
evaluation in this study. Twelve of the 30 patients were positive for
H. pylori, based on histological detection, and had active
chronic gastritis. The 18 uninfected patients had normal gastric
mucosa. Based on endoscopic examination, 11 of the 12 H. pylori-positive patients had uncomplicated chronic gastritis; only
1 patient had duodenal ulcers. CD4+ cells from 10 of the 12 H. pylori-positive patients were analyzed by FACS. Yields of
viable mononuclear cells derived from the biopsy specimens of H. pylori-infected patients or noninfected control patients ranged
from 102 to 105; however, cell numbers in
H. pylori-infected patients usually were three to four times
higher (data not shown).
Accordingly, as depicted in Fig. 1, the
average relative number of CD4+ cells present in biopsy
specimens, as assessed by FACS analysis, was about seven times higher
in H. pylori-positive patients than in control patients.
Therefore, the majority of analyzed CD4+ lymphocytes
derived from the gastric mucosa of H. pylori-infected patients are related to the infection.
After stimulation of the cells, between 10 and 60% of the
CD4+ T cells derived from H. pylori-positive
patients stained positively for IFN-
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Antrum- and Corpus Mucosa-Infiltrating
CD4+ Lymphocytes in Helicobacter pylori
Gastritis Display a Th1 Phenotype
ABSTRACT
Top
Abstract
Text
References
TEXT
Top
Abstract
Text
References
) (12, 13). However, these studies did not differentiate
between CD4+, CD8+, and NK cells. Very
recently, the technique of intracellular staining of cytokines was used
to demonstrate that CD4+ and CD8+ cells from
the antrum region of patients with H. pylori gastritis produce IFN- but nearly no interleukin-4 (IL-4) (2). Far
less characterized are immune responses in the corpus region of the stomach. Because corpus-predominant H. pylori gastritis is
associated with the appearance of autoantibodies and atrophic changes
(8, 18), the T-cell response in the corpus region may be
different.
and IL-4) were stained
intracellularly in CD4+ and CD8+ cells prepared
from gastric mucosa either of patients with H. pylori-positive gastritis or of patients without gastritis. The patients enrolled in this study underwent upper gastrointestinal endoscopy for diagnostic reasons. At least four biopsy specimens each
were obtained from the gastric antrum and corpus regions of each
patient. Two biopsy specimens from each location were processed for
histological examination, and the remaining two specimens were
processed for cytokine analysis of infiltrating lymphocytes. For the
latter purpose, the biopsy specimens were mechanically disrupted with a
mesh (Costar Netwell, 74 µm) and single-cell suspensions were
prepared. Thereafter, the cells were washed once in balanced salt
solution and suspended in Click's medium, supplemented as described
previously (24) and containing brefeldin A at 10 µg/ml.
For activation of the cells, phorbol-12-myristate-13-acetate (50 ng/ml)
and ionomycin (750 ng/ml) were added. After 4 h of incubation at
37°C, the cells were washed in phosphate-buffered saline (PBS), fixed
with 2% formaldehyde solution for 20 min, and split into two aliquots.
The cells were then incubated for 20 min in saponin buffer (PBS
containing 0.5% saponin and 3% fetal calf serum) containing either
fluorescein isothiocyanate (FITC)-conjugated mouse immunoglobulin G1
(IgG1) isotype control antibody (Ab) (2.5 µg/ml) and phycoerythrin
(PE)-conjugated rat IgG1 isotype control Ab (5 µg/ml [aliquot 1])
or FITC-conjugated anti-IFN- Ab (2.5 µg/ml), PE-conjugated
anti-IL-4 Ab (5 µg/ml), and CyChrome-conjugated anti-CD4 Ab (aliquot
2). Instead of an isotype control Ab, for two patients aliquot 1 contained FITC-conjugated anti-IFN- Ab, PE-conjugated anti-IL-4 Ab,
and CyChrome-conjugated anti-CD8 Ab (1:100) in order to simultaneously
analyze cytokine production by CD4+ and CD8+
cells. After this step, cells were washed twice in saponin buffer and
once in PBS and then analyzed by fluorescence-activated cell sorting
(FACS) in a FACScan (Becton Dickinson) with Lysys II software. For FACS
analysis, a forward/side scatter-based gate, which did not contain
larger cells (for example, macrophages), was chosen.
View larger version (14K):
[in a new window]
FIG. 1.
Relative numbers of CD4+ T cells present in
gastral biopsy specimens of H. pylori-infected patients and
uninfected control patients. T cells were isolated from gastral biopsy
specimens as described in the text and processed for intracellular
staining of cytokines and CD4. Thereafter, the cells were resuspended
in PBS and analyzed by FACS. The figure shows mean numbers of antrum
and corpus CD4+ T cells present in 100 µl of PBS, as
measured by FACS. H.p., H. pylori.
(Table
1). A representative FACS analysis of
antrum and corpus CD4+ cells is shown in Fig.
2. In contrast, IL-4-positive
CD4+ cells were not detected, with the exception of one
H. pylori-positive patient whose CD4+ cells
contained a low percentage of IL-4-positive cells (3% of the
CD4+ cells [data not shown]). No major differences in the
cytokine profiles of T cells isolated from the antrum and corpus
regions were observed. The few CD4+ cells isolated from
uninfected control patients also showed a clear Th1 phenotype (data not
shown). The validity and sensitivity of the IL-4 antibody were
confirmed by showing that this antibody was able to stain up to 10% of
stimulated human peripheral T cells that had been cultured for 2 weeks
in the presence of IL-2 and IL-4 (Fig.
3). In contrast, the antibody did not
stain freshly isolated, activated peripheral blood CD4+
cells (data not shown). Specific binding of the anticytokine antibodies
was further proven by using isotype-matched PE- or FITC-coupled control
antibodies, which did not stain more than 0.3% of the CD4+
or CD8+ T cells (Fig. 2A and B). Due to the limiting
numbers of T cells present in the specimens, in four patients T cells
from only one location (corpus or antrum) could be analyzed. In all
cases, CD4-negative cells also contained a high proportion of
IFN--positive cells. In biopsy specimens from two patients, it was
demonstrated that this IFN- is mainly produced by CD8+
cells (data not shown). IL-4-positive CD8+ cells were not
detected.
TABLE 1.
IFN- -positive and IL-4-positive CD4+ T
cells in biopsy specimens of patients with
H. pylori gastritisa
View larger version (38K):
[in a new window]
FIG. 2.
IFN- production by T cells isolated from the stomach
of a patient with H. pylori-positive gastritis. T cells were
isolated from the antrum (A and C) and corpus (B and D) regions. The T
cells were stimulated, and intracellular staining of CD4, IFN-, and
IL-4 was performed as described in the text. (A and B) Staining with
control Abs, which were isotype matched to the anticytokine Abs:
y axes, FITC-conjugated mouse IgG1 isotype control Ab;
x axes, PE-conjugated rat IgG1-PE isotype control Ab. (C and
D) Staining with CyChrome-conjugated anti-CD4 Ab (x axes)
and FITC-conjugated anti-IFN- Ab (y axes).
View larger version (20K):
[in a new window]
FIG. 3.
IFN- and IL-4 production by peripheral T cells.
Peripheral blood mononuclear cells were isolated from heparinized blood
of a healthy donor by using a Ficoll-Hypaque density gradient. The
cells were cultured in Click's medium for two weeks in the presence of
recombinant human IL-2 (10 U/ml) and recombinant human IL-4 (20 U/ml).
Thereafter, the cells were left untreated (left) or stimulated (right),
and intracellular staining of CD4, IFN-, and IL-4 was performed as
described in the text. Gating was restricted to CD4+ cells
according to staining with anti-CD4 CyChrome. x axes,
staining with FITC-conjugated anti-IFN- Ab; y axes,
staining with PE-conjugated anti-IL-4 Ab.
These data show that CD4+ as well as CD8+ lymphocytes infiltrating the gastric mucosa during chronic H. pylori gastritis have a Th1 phenotype and that Th0 and Th2 are not present. Of note, all analyzed T cells displayed this Th1 pattern regardless of whether they were isolated from the antrum or corpus region, demonstrating that the T-cell responses against H. pylori do not differ between the antral and corpus regions.
Regarding antral T cells, our results confirm data very recently obtained by Bamford et al. (2) by a similar technique. However, in their study, CD4 was measured only on the surface of the cells. Since phorbol-12-myristate-13-acetate stimulation leads to downregulation of CD4 from the T-cell surface, only those T cells whose CD4 expression is not lost after stimulation were analyzed in that study. These T-cell populations, however, may not represent all CD4+ T cells in the stomach. For this reason, CD4 was measured intracellularly in the present study, which allowed clear discrimination between CD4+ and CD4-negative cells even after stimulation.
Analysis of CD4+ T-cell responses in human H. pylori gastritis has also been addressed by analysis of H. pylori-specific T-cell clones, which were cloned from the antral
gastric mucosa of H. pylori-infected patients
(5-7). In an apparent contradiction of our results, in one
of these studies most of the T-cell clones from patients with
uncomplicated chronic gastritis (without ulcer) displayed a Th0
phenotype (5). A possible explanation for this apparent
discrepancy is that the H. pylori-specific Th0 cell clones were generated by multiple antigenic restimulation of gastric T cells
in vitro. Alternatively, the frequency of H. pylori-specific Th0 cells within CD4+ cells in biopsy specimens is so low
that they cannot be detected by the method applied herein. On the other
hand, the observation that mRNA for IFN- and IL-12 is expressed in
the gastric mucosa of infected patients (6, 14) would be in
accordance with our results. Since IL-12 is known to shift the immune
response towards Th1 (22, 25), expression of IL-12 at the
local site of H. pylori infection could favor the in situ
development of a Th1 response against H. pylori.
What could be the relevance of a polarized Th1-response in H. pylori gastritis? In a mouse infection model using
Helicobacter felis, it was demonstrated that Th1 cells
contributed to disease whereas Th2 cells were protective because they
reduced the bacterial load in the stomach of mice (17). The
protective effect of a Th2-type response may result from the induction
of local IgA production (15). If this concept also applies
for H. pylori and humans, H. pylori might have
gained the ability to evoke the "wrong" (Th1) immune response
during its evolutionary adaptation to the stomach mucosa. The Th1
response may block the development of a protective (Th2) immune
response and induce chronic inflammation by production of IFN-. A
possible mechanism for the detrimental effect of IFN- produced by
Th1 cells during H. pylori gastritis, as previously suggested, is induction of major histocompatibility complex class II
molecules, which may lead to enhanced adherence of H. pylori to epithelial cells and consequent apoptosis (9). Further
investigations will have to investigate the mechanisms which influence
the balance of the Th1/Th2 response during H. pylori
infection.
| |
ACKNOWLEDGMENTS |
|---|
We thank Barbara Bodendorfer and Claudia Gießler for perfect technical assistance.
This work was supported by the Interdisziplinäres Zentrum für Klinische Forschung of the University of Erlangen (project A4).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institut für Klinische Mikrobiologie, Immunologie und Hygiene der Universität Erlangen-Nürnberg, Wasserturmstr. 3, 91054 Erlangen, Germany. Phone: 49/9131/852577. Fax: 49/9131/852573. E-mail: sommer{at}mikrobio.med.uni.erlangen.de.
Editor: J. R. McGhee
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. | Appelmelk, B. J., R. Negrini, A. P. Moran, and E. J. Kuipers. 1997. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol. 5:70-73[Medline]. |
| 2. | Bamford, K. B., X. Fan, S. E. Crowe, J. F. Leary, W. K. Gourley, G. K. Luthra, E. G. Brooks, D. Y. Graham, V. E. Reyes, and P. B. Ernst. 1998. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482-492[Medline]. |
| 3. |
Covacci, A.,
S. Censini,
M. Bugnoli,
R. Petracca,
D. Burroni,
G. Macchia,
A. Massone,
E. Papini,
Z. Y. Xiang,
N. Figura, and R. Rappuoli.
1993.
Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.
Proc. Natl. Acad. Sci. USA
90:5791-5795 |
| 4. |
Cover, T. L., and M. J. Blaser.
1992.
Purification and characterization of the vacuolating toxin from Helicobacter pylori.
J. Biol. Chem.
267:10570-10575 |
| 5. | D'Elios, M. M., M. Manghetti, F. Almerigogna, A. Amedei, F. Costa, D. Burroni, C. T. Baldari, S. Romagnani, J. L. Telford, and G. Del Prete. 1997. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur. J. Immunol. 27:1751-1755[Medline]. |
| 6. | D'Elios, M. M., M. Manghetti, M. De Carli, F. Costa, C. T. Baldari, D. Burroni, J. L. Telford, S. Romagnani, and G. Del Prete. 1997. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962-967[Abstract]. |
| 7. | Di Tommaso, A., Z. Xiang, M. Bugnoli, P. Pileri, N. Figura, P. F. Bayell, R. Rappuoli, S. Abrignani, and M. T. De Magistris. 1995. Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsies. Infect. Immun. 63:1102-1106[Abstract]. |
| 8. |
Faller, G.,
H. Steininger,
J. Kranzlein,
H. Maul,
T. Kerkau,
J. Hensen,
E. G. Hahn, and T. Kirchner.
1997.
Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis.
Gut
41:619-623 |
| 9. |
Fan, X.,
S. E. Crowe,
S. Behar,
H. Gunasena,
G. Ye,
H. Haeberle,
N. Van Houten,
W. K. Gourley,
P. B. Ernst, and V. E. Reyes.
1998.
The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage.
J. Exp. Med.
187:1659-1669 |
| 10. |
Fan, X. J.,
A. Chua,
C. N. Shahi,
J. McDevitt,
P. W. Keeling, and D. Kelleher.
1994.
Gastric T lymphocyte responses to Helicobacter pylori in patients with H. pylori colonisation.
Gut
35:1379-1384 |
| 11. | Forman, D., D. G. Newell, F. Fullerton, J. W. Yarnell, A. R. Stacey, N. Wald, and F. Sitas. 1991. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br. Med. J. 302:1302-1305. |
| 12. | Haeberle, H. A., M. Kubin, K. B. Bamford, R. Garofalo, D. Y. Graham, F. El-Zaatari, R. Karttunen, S. E. Crowe, V. E. Reyes, and P. B. Ernst. 1997. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect. Immun. 65:4229-4235[Abstract]. |
| 13. |
Karttunen, R.,
T. Karttunen,
H. P. Ekre, and T. T. MacDonald.
1995.
Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis.
Gut
36:341-345 |
| 14. | Karttunen, R. A., T. J. Karttunen, M. M. Yousfi, H. M. el-Zimaity, D. Y. Graham, and F. A. El-Zaatari. 1997. Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand. J. Gastroenterol. 32:22-27[Medline]. |
| 15. | Lee, C. K., R. Weltzin, W. D. Thomas, Jr., H. Kleanthous, T. H. Ermak, G. Soman, J. E. Hill, S. K. Ackerman, and T. P. Monath. 1995. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis. 172:161-172[Medline]. |
| 16. | Marshall, B. J., and J. R. Warren. 1984. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet i:1311-1315. |
| 17. | Mohammadi, M., J. Nedrud, R. Redline, N. Lycke, and S. J. Czinn. 1997. Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 113:1848-1857[Medline]. |
| 18. | Negrini, R., A. Savio, C. Poiesi, B. J. Appelmelk, F. Buffoli, A. Paterlini, P. Cesari, M. Graffeo, D. Vaira, and G. Franzin. 1996. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 111:655-665[Medline]. |
| 19. | Papadimitriou, C. S., E. E. Ioachim-Velogianni, E. B. Tsianos, and H. M. Moutsopoulos. 1988. Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis. Virchows Arch. A 413:197-204. |
| 20. |
Parsonnet, J.,
S. Hansen,
L. Rodriguez,
A. B. Gelb,
R. A. Warnke,
E. Jelum,
N. Orentreich,
J. H. Vogelman, and G. D. Friedman.
1994.
Helicobacter pylori infection and gastric lymphoma.
N. Engl. J. Med.
330:1267-1271 |
| 21. | Rauws, E. A. J., and G. N. J. Tytgat. 1990. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335:1233-1235[Medline]. |
| 22. | Romagnani, S. 1992. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int. Arch. Allergy Immunol. 98:279-285[Medline]. |
| 23. |
Sobala, G. M.,
J. E. Crabtree, and M. F. Dixon.
1991.
Acute Helicobacter infection: clinical features, local and systemic immune response, gastric mucosal histology and gastric juice ascorbic acid concentration.
Gut
32:1415-1418 |
| 24. | Solbach, W., K. Forberg, E. Kammerer, C. Bogdan, and M. Röllinghoff. 1986. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice. J. Immunol. 137:702-707[Abstract]. |
| 25. | Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276[Medline]. |
| 26. | Warren, J. R., and B. Marshall. 1983. Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet i:1273-1275. |
| 27. | Wotherspoon, A. C., C. Ortiz-Hidalgo, M. R. Falzon, and P. G. Isaacson. 1991. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175-1176[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|
